Interactions between inflammatory and oxidative stress in preeclampsia

Hypertension in Pregnancy

Volumn 28, Issue 1, 2009, Pages 56-62

  Ouyang, Yan Qiong ^a   Li, Si Jian ^a   Zhang, Qing ^a   Cai, Hong Bin ^a   Chen, Han Ping ^b  

^a WUHAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Inflammation; Oxidative stress; Preeclampsia; Pregnancy

Indexed keywords

8 ISOPROSTANE; C REACTIVE PROTEIN; INTERLEUKIN 6; MALONALDEHYDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GESTATIONAL AGE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PREECLAMPSIA;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DINOPROST; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALONDIALDEHYDE; OXIDATIVE STRESS; PRE-ECLAMPSIA; PREGNANCY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 60749134702     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.1080/10641950802233064     Document Type: Article

References (24)

1. Raijmakers MTM, Dechend R, Poston L. Oxidative stress and preeclampsia. Rationale for antioxidant clinical trials. Hypertension 2004; 44:374-379.
2. Redman CWG, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308:1592-1594.
3. Borzychowski AM, Sargent IL, Redman CW. Inflammation and preeclampsia. Semin Fetal Neonatal Med 2006; 11:309-316.
4. Redman CWG, Sargent IL. Preeclampsia, the placenta and the maternal systemic inflammatory response - a review. Placenta 2003; 24:S21-S27.
5. Freeman DJ, McManus F, Brown EA, Cherry L, Norrie J, Ramsay JE, et al. Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 2004; 44:708-716.
6. Redman CWG, Sacks GP, Sargeant IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499-506.
7. Roberts JM, Hubel CA. Oxidative stress in preeclampsia. Am J Obstet Gynecol 2004; 190:1177-1178.
8. Morris JM, Gopaul NK, Endresen MJR, Knight M, Linton EA, Dhir S, et al. Circulating markers of oxidative stress are raised in normal pregnancy and preeclampsia. Br J Obstet Gynaecol 1998; 105:1195-1199.
9. Wang Y, Walsh SW. Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in preeclampsia. Placenta 2001; 22:206-212.
10. Sankaralingam S, Arenas IA, Lalu MM, Davidge ST. Preeclampsia: current understanding of the molecular basis of vascular dysfunction. Expert Rev Mol Med 2006; 26:1-20.
11. Brown MA, Lindheimer MD, de Swiet M, van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20:IX-XIV.
12. Bodnar LM, Ness RB, Harger GF, Roberts JM. Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia. Am J Epidemiol 2005; 162:1198-1206.
13. Walsh SW, Vaughan JE, Wang Y, Roberts J. Placental isoprostane is significantly increased in preeclampsia. FASEB J 2000; 14:1289-1296.
14. O'Brien TE, Ray JG, Chan WS. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 2003; 14:368-374.
15. Barden A, Beilin LJ, Ritchie J, croft KD, Walters BN, Michael CA. Plasma and urinary 8-isoprostane as an indicator of lipid peroxidation in preeclampsia and normal pregnancy. Clin Sci 1996; 91:711-718.
16. Roberts JM, Hubel CA. Is oxidative stress the link in the two-stage model of preeclampsia? Lancet 1999; 354:788-789.
17. Harma M, Harma M, Erel O. Oxidative stress in women with preeclampsia. Am J Obstet Gynecol 2005; 192:656-657.
18. Montuschi P, Barnes PJ, Roberts LJ. Isoprostanes: markers and mediators of oxidative stress. FASEB J 2004; 18:1791-1800.
19. Aksoy H, Taysi S, Altinkaynak K, Bakan E, Bakan N, Kumtepe Y. Antioxidant potential and transferrin, ceruloplasmin and lipid peroxidation levels in women with preeclampsia. J Invest Med 2003; 51:284-287.
20. Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension 2005; 46:1243.
21. Barden A, Ritchie J, Walters B, Michael C, Rivera J, Mori T, et al. Study of plasma factors associated with neutrophil activation and lipid peroxidation in preeclampsia. Hypertension 2001; 38:803-808.
22. Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP: Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001; 86:2505-2512.
23. Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WH, Hale EA, Martin JNJ, et al. Expression of the placental cytokines tumor necrosis factor? interleukin 1β, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol 1999; 181:915-920.
24. Teran E, Escudero C, Calle A. C-reactive protein during normal pregnancy and preeclampsia. Int J Gynecol Obstet 2005; 89:299-300.